Cargando…

Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion

PURPOSE: To evaluate the prognostic factors and outcomes of dexamethasone intravitreal implant (DEX implant) for intravitreal bevacizumab refractory macular edema secondary to branch retinal vein occlusion (BRVO). METHODS: This was a retrospective, interventional case series. Medical records were re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Kyou Ho, Kang, Eui Chun, Koh, Hyoung Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Ophthalmological Society 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368083/ https://www.ncbi.nlm.nih.gov/pubmed/28367038 http://dx.doi.org/10.3341/kjo.2017.31.2.108

Ejemplares similares

Angiographically Documented Macular Ischemia after Single Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion
por: Lee, Kyou Ho, et al.
Publicado: (2017)

Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
por: Demir, Mehmet, et al.
Publicado: (2011)

Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
por: Thapa, Raba, et al.
Publicado: (2012)

Comparison Between Intravitreal Bevacizumab and Triamcinolone for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Kim, Jin Young, et al.
Publicado: (2009)

The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
por: Gokce, Gokcen, et al.
Publicado: (2014)

Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Wang, Jia-Kang, et al.
Publicado: (2016)

Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab
por: Yoo, Seul Gi, et al.
Publicado: (2015)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
por: Laine, Ilkka, et al.
Publicado: (2017)

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
por: Gutiérrez, Juan Carlos Mesa, et al.
Publicado: (2008)

Treatment of Branch Retinal Vein Occlusion induced Macular Edema with Bevacizumab
por: Abegg, Mathias, et al.
Publicado: (2008)

Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab
por: Yunoki, Tatsuya, et al.
Publicado: (2013)

Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
por: Choi, Eun Young, et al.
Publicado: (2019)

Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
por: Udaondo, Patricia, et al.
Publicado: (2011)

Intravitreal Bevacizumab Alone or Combined with Macular Laser Photocoagulation for Recurrent or Persistent Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Hirashima, Takafumi, et al.
Publicado: (2014)

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
por: Yalamanchi, Shalini, et al.
Publicado: (2011)

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
por: Ivanovska Adjievska, Biljana, et al.
Publicado: (2017)

Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
por: Matonti, Frederic, et al.
Publicado: (2012)

Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion
por: Jaissle, Gesine B., et al.
Publicado: (2010)

Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion
por: Ito, Yuka, et al.
Publicado: (2015)

Natural Short-term Course of Recurrent Macular Edema Following Intravitreal Bevacizumab Therapy in Branch Retinal Vein Occlusion
por: Yoo, Su Jin, et al.
Publicado: (2017)

OCT angiography features associated with macular edema recurrence after intravitreal bevacizumab treatment in branch retinal vein occlusion
por: Choi, Kwang-Eon, et al.
Publicado: (2019)

Comparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion
por: Son, Bo Kwon, et al.
Publicado: (2017)

A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Bayat, Alper Halil, et al.
Publicado: (2019)

Microaneurysms cause refractory macular edema in branch retinal vein occlusion
por: Tomiyasu, Taneto, et al.
Publicado: (2016)

Initial Dose of Three Monthly Intravitreal Injections versus PRN Intravitreal Injections of Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Ahn, Seong Joon, et al.
Publicado: (2013)

Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex(®)) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion
por: Chan, Annie, et al.
Publicado: (2011)

Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion
por: Kumagai, Kazuyuki, et al.
Publicado: (2019)

Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion
por: Ogino, Ken, et al.
Publicado: (2011)

Changes of retinal flow volume after intravitreal injection of bevacizumab in branch retinal vein occlusion with macular edema: a case series
por: Noma, Hidetaka, et al.
Publicado: (2016)

Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion
por: Huang, Yu-Te, et al.
Publicado: (2021)

Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion
por: Moon, Su Young, et al.
Publicado: (2018)

Comparison of dexamethasone intravitreal implant with intravitreal anti-VEGF injections for the treatment of macular edema secondary to branch retinal vein occlusion: A meta-analysis
por: Ji, Kaibao, et al.
Publicado: (2019)

Reversal of Early Central Retinal Vein Occlusion by Alleviating Optic Nerve Edema with an Intravitreal Dexamethasone Implant
por: Cho, Young Joo, et al.
Publicado: (2014)

Intravitreal injection of conbercept combined with retinal photocoagulation on macular edema secondary to branch retinal vein occlusion
por: Wang, Bing, et al.
Publicado: (2020)

Evaluation of the Effectiveness of Treatment with Dexamethasone Intravitreal Implant in Cystoid Macular Edema Secondary to Retinal Vein Occlusion
por: Donati, Simone, et al.
Publicado: (2018)

Effects of intravitreal bevacizumab on reduced visual acuity and macular thickness secondary to branch retinal vein occlusion
por: Eltutar, Kadir, et al.
Publicado: (2013)

Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion
por: Hikichi, Taiichi, et al.
Publicado: (2014)

Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema
por: Altintas, Ayse Gul Kocak, et al.
Publicado: (2019)

Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion
por: Deka, Satyen, et al.
Publicado: (2009)

Efficacy of combined intravitreal bevacizumab and triamcinolone for branch retinal vein occlusion
por: Ali, Rasha I, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_maujpdrjkq77hksvfhqg47idm9